Related Experiment Video
Updated: Oct 8, 2025

06:58
Method and Instrumented Fixture for Femoral Fracture Testing in a Sideways Fall-on-the-Hip Position
Published on: August 17, 2017
10.1K
Comparative Studies in the Shoulder Literature Lack Statistical Robustness: A Fragility Analysis
Robert L Parisien1, David P Trofa2, Patrick K Cronin3
1Boston University Medical Center, Boston, Massachusetts.
Arthroscopy, Sports Medicine, and Rehabilitation
|January 3, 2022
Summary
Comparative shoulder studies often lack statistical robustness, as a few outcome reversals can alter significance. Fragility analysis, using the fragility index (FI) and fragility quotient (FQ), is crucial for assessing the reliability of published orthopaedic shoulder research.
Area of Science:
- Orthopaedic Surgery
- Biostatistics
- Clinical Research Methodology
Background:
- Evidence-based decision-making relies on comparative clinical studies.
- A small number of outcome reversals can significantly impact study conclusions.
- Fragility analysis assesses the statistical robustness of study findings.
Purpose of the Study:
- To evaluate the utility of fragility analysis in comparative orthopaedic shoulder studies.
- To determine the statistical fragility of published shoulder research.
Main Methods:
- Analysis of comparative clinical shoulder studies (1:1 dichotomous data) from 2006-2016 in 6 leading journals.
- Calculation of fragility index (FI) and fragility quotient (FQ) for study outcomes.
- Statistical significance defined as P < 0.05.
Main Results:
- 198 comparative studies were analyzed; 67 were randomized controlled trials.
- The median FI was 4 (IQR 2-6) and the median FQ was 0.066 (IQR 0.038-0.102).
- No significant difference in statistical fragility was found between randomized and non-randomized trials.
Conclusions:
- Comparative shoulder studies in leading orthopaedic journals exhibit statistical fragility.
- The P-value alone may be insufficient for interpreting study significance.
- Reporting FI and FQ alongside P-values is recommended for a comprehensive understanding of trial stability.

